ArticleJournal of human hypertension2026
Antihypertensive treatment and adverse psychiatric reactions in primary health care.
Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antihypertensive treatment (AHT) has been associated with adverse psychiatric reactions (APRs), but existing data are conflicting. The aim of the present study was to determine the risk for seven different APRs in drug-naive patients with newly diagnosed hypertension in primary health care. This cohort study analyzed registry data of individuals aged 40-70 with a newly diagnosed untreated hypertension without previous psychiatric or cardiovascular comorbidities in Swedish primary healthcare from 2006 and onwards. Adjusted Cox proportional hazard ratios (aHRs) with 95% confidence intervals (CIs) were estimated with seven different AHTs as time-dependent variables. Seven different APRs outcomes were studied. Bonferroni correction was used. Among 677,564 studied individuals (51% female, mean age [±standard deviation] 58.0 [ ± 7.7] years), the highest risks of APRs occurred within the first two years of AHT. All AHTs were associated with one or more APRs. Beta-blockers showed strongest associations with APR. During the first two years after diagnosis of hypertension, beta-blockers were significantly associated with substance abuse disorders (aHR=1.48, 95%CI 1.43-1.54), psychotic disorders (aHR=1.46, 95%CI 1.27-1.68), affective disorders (aHR=1.35, 95%CI 1.32-1.39), bipolar disorders (aHR=1.34, 95%CI 1.12-1.61), depressive disorders (aHR=1.36, 95%CI 1.32-1.40), anxiety disorders (aHR=1.51, 95%CI 1.48-1.54), and sleep disorders (aHR=1.27, 95%CI 1.24-1.30). Certain associations remained in a co-sibling analysis. AHTs are associated with several APRs especially during the first two years after diagnosis of hypertension. However, it is important to note that only association but not causality can be inferred due to persistent confounding that could not be practically adjusted for.
Identifiers
42660983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.